Field Studies Clause Samples

The Field Studies clause defines the terms under which one party may conduct research, testing, or data collection activities in real-world environments relevant to the agreement. Typically, this clause outlines the scope of permissible activities, requirements for obtaining necessary permissions, and obligations regarding confidentiality or data handling. By establishing clear guidelines for conducting field studies, the clause ensures that such activities are carried out ethically, legally, and with minimal disruption, thereby protecting the interests of all parties involved.
Field Studies. A regular faculty member teaching field school (including studies abroad) except those courses which are offered through a field school and which are a program requirement that can only be fulfilled by attendance at the field school shall be paid in accordance with Article 11.1.4.2.
Field Studies. It is the process that allows obtaining data of the geographic areas where the Mandatory Investment Commitment is to be developed, in order to evaluate them and based on this make the decisions and strategies to develop the same.
Field Studies. Apex will prepare one Aquatic Resource Delineation Report in accordance with the USACE Minimum Standards, 1987 Wetland Delineation Manual, Regional Supplement to the Corps of Engineers Wetland Delineation Manual: Great Plains Region, USACE RGL 05-05, and the NDDOT Design Manual, identifying all wetlands or waters that occur within the study area, as well as tree/shrub survey results. This includes the field work to obtain the aquatic resource and other boundaries surveyed using a sub-meter precision GPS unit. Apex will collect Ordinary High Water Mark (OHWM) and drainage locations in areas where applicable.
Field Studies. Field studies would allow students to work with a community partner in an internship or apprentice role outside of the school. By closely working with their teacher-coach and the community partner, the student would earn a portion of their credit for subjects relating to the field studies plan.
Field Studies. Engineers are people who use scientific thinking to design, construct, and maintain structures, engines, and machines. Watch this video to learn about different kinds of engineers: ▇▇▇▇▇://▇▇▇.▇▇▇▇▇▇▇.▇▇▇/watch?v=owHF9iLyxic • Which kind of engineering interests you the most? Why? • What would you need to study and learn to become that kind of engineer?
Field Studies. What is keeping the Leaning Tower of Pisa from toppling over for the past 800 years? Gravity. The tower does not fall because its center of gravity has been kept within its base. Read about it here: http:// ▇▇▇.▇▇▇▇▇▇▇▇▇▇▇.▇▇▇/▇▇▇▇▇▇▇-▇▇▇▇▇-▇▇-▇▇▇▇-▇▇▇▇▇/. Watch the ▇▇▇-▇▇ video on how it was created and remains standing today: ▇▇▇▇▇://▇▇▇▇▇.▇▇/ HFqf6aKdOC0 To imitate the leaning tower, find a safe spot, stand still with both feet planted firmly together and arms to your sides. Did you feel your center of gravity shifting? Now try leaning to the other side. Did your feet move from their spot? Just like the Leaning Tower of Pisa, your center of gravity is maintaining your balance. How do engineers take the center of gravity into account when designing structures today?
Field Studies. In the context of the German Egyptian Long term Scholarship Program (GERLS) abroad Field Studies needed by GERLS candidates during their residence in Germany could be funded on the following conditions: 1. The candidate should inform the final selection committee about the required field study for his/her research. Therefore, the final selection committee should approve the necessity of the field studies in order to take place during the duration of the scholarship. However, if the candidate decides to include a Field Study for his/her research after the final selection, then a member of the final selection committee should be consulted and provide DAAD with the committee decision in writing. 2. For Channel & Specialization candidates: The field study may be completed either before the start of the scholarship or after finishing the scholarship according to the agreement with both supervisors. This approval by the supervisors, however, needs to be obtained before the final selection takes place and the relevant document has to be submitted to the selection committee. 3. An official letter, signed by the GERLS candidate's German supervisor, indicating his/her approval on the necessity of the Field Study for the research should be submitted to DAAD. 4. For full PhD candidates: The duration of the field study abroad should not exceed a quarter of the entire scholarship duration provided for the candidate (a maximum of 12 months). For candidates who require more than one Field Study trip, then the duration of all Field Study trips should not exceed the above mentioned limit. 5. A total of 3 months funding/allowance (that includes the full scholarship rate and other subsidies) will be paid for the Field Study trip, whether it is used during one field trip or several trips. If the duration of the entire Study Field trip(s) will take more than 3 months, then neither the scholarship rate nor the subsidies will be further provided for the candidate. 6. As for the travel allowance, it will be provided only for one Field Study trip, whether it is used to travel to the candidate's home country of origin or to another country or as a replacement of the return home journey during the scholarship.
Field Studies. Mapping - is of special interest for dam and powerhouse and reservoir locations. Aerial mapping with some ground control areas was performed of these critical areas. Detailed mapping was performed for feasibility design of dam, powerhouse, tunnels and intake and outlet areas. Reservoir area mapping was used to determine storage volume and for Geology - field studies can be categorised as either defining subsurface material properties for design and construction or for determining sources for construction materials. Major geological field investigations on this project included:

Related to Field Studies

  • Clinical Studies The animal and other preclinical studies and clinical trials conducted by the Company or on behalf of the Company were, and, if still pending are, to the Company’s knowledge, being conducted in all material respects in compliance with all Applicable Laws and in accordance with experimental protocols, procedures and controls generally used by qualified experts in the preclinical study and clinical trials of new drugs and biologics as applied to comparable products to those being developed by the Company; the descriptions of the results of such preclinical studies and clinical trials contained in the Registration Statement and the Prospectus are accurate and complete in all material respects, and, except as set forth in the Registration Statement and the Prospectus, the Company has no knowledge of any other clinical trials or preclinical studies, the results of which reasonably call into question the clinical trial or preclinical study results described or referred to in the Registration Statement and the Prospectus when viewed in the context in which such results are described; and the Company has not received any written notices or correspondence from the FDA, the EMA, or any other domestic or foreign governmental agency requiring the termination, suspension or modification of any preclinical studies or clinical trials conducted by or on behalf of the Company that are described in the Registration Statement and the Prospectus or the results of which are referred to in the Registration Statement and the Prospectus.

  • Clinical Trials The studies, tests and preclinical and clinical trials conducted by or on behalf of, or sponsored by, the Company, or in which the Company has participated, that are described in the Registration Statement or the Prospectus, or the results of which are referred to in the Registration Statement or the Prospectus, were and, if still pending, are being conducted in all material respects in accordance with protocols, procedures and controls pursuant to, where applicable, accepted professional and scientific standards for products or product candidates comparable to those being developed by the Company and all applicable statutes, rules and regulations of the FDA, the EMA, Health Canada and other comparable regulatory agencies outside of the U.S. to which they are subject, including, without limitation, 21 C.F.R. Parts 50, 54, 56, 58, 312, and 812; the descriptions of the results of such studies, tests and trials contained in the Registration Statement or the Prospectus do not contain any misstatement of a material fact or omit a material fact necessary to make such statements not misleading; the Company has no knowledge of any studies, tests or trials not described in the Registration Statement or the Prospectus the results of which reasonably call into question in any material respect the results of the studies, tests and trials described in the Registration Statement or Prospectus; and the Company has not received any notices or other correspondence from the FDA, EMA, Health Canada or any other foreign, state or local governmental body exercising comparable authority or any Institutional Review Board or comparable authority requiring or threatening the termination, suspension or material modification of any studies, tests or preclinical or clinical trials conducted by or on behalf of, or sponsored by, the Company or in which the Company has participated, and, to the Company’s knowledge, there are no reasonable grounds for the same. Except as disclosed in the Registration Statement and the Prospectus, there has not been any violation of law or regulation by the Company in its respective product development efforts, submissions or reports to any regulatory authority that could reasonably be expected to require investigation, corrective action or enforcement action.

  • Commercialization Intrexon shall have the right to develop and Commercialize the Reverted Products itself or with one or more Third Parties, and shall have the right, without obligation to Fibrocell, to take any such actions in connection with such activities as Intrexon (or its designee), at its discretion, deems appropriate.

  • Development Activities The Development activities referred to in item “b” of paragraph 3.1 include: studies and projects of implementation of the Production facilities; drilling and completion of the Producing and injection ▇▇▇▇▇; and installation of equipment and vessels for extraction, collection, Treatment, storage, and transfer of Oil and Gas. The installation referred to in item “c” includes, but is not limited to, offshore platforms, pipelines, Oil and Gas Treatment plants, equipment and facilities for measurement of the inspected Production, wellhead equipment, production pipes, flow lines, tanks, and other facilities exclusively intended for extraction, as well as oil and gas pipelines for Production Outflow and their respective compressor and pumping stations.

  • Trials The Ship shall run the following test and trials: (1) Harbour Acceptance Tests, including setting to work of the various equipment;